^
Association details:
| Biomarker: | COL1A1-PDGFB fusion |
|---|---|
| Cancer: | Soft Tissue Sarcoma |
| Drug: | imatinib (c-KIT inhibitor, Bcr-abl tyrosine kinase inhibitor, PDGFR inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
OFP-24-003 | Clinicopathological Features of Dermatofibrossarcoma Protuberans Treated with Imatinib
Published date:
08/05/2021
Excerpt:
All underwent treatment with Imatinib 400mg. Clinical reduction in tumor size was seen in all cases. Fibrossarcomatous DFSP was diagnosed in 3 patients, with COL1A1-PDGFB fusion detected in 2.
